Skip to Content
Merck
CN
  • Decrease of pyruvate dehydrogenase phosphatase activity in patients with congenital lactic acidemia.

Decrease of pyruvate dehydrogenase phosphatase activity in patients with congenital lactic acidemia.

Clinica chimica acta; international journal of clinical chemistry (1992-07-31)
M Ito, H Kobashi, E Naito, T Saijo, E Takeda, A H Huq, Y Kuroda
ABSTRACT

We developed an assay method for pyruvate dehydrogenase phosphatase activity using [1-14C]pyruvate and measured pyruvate dehydrogenase phosphatase activity in cultured skin fibroblasts from three patients with congenital lactic acidemia due to a defect in activation of the pyruvate dehydrogenase complex. The enzyme activity of their fibroblasts was significantly reduced to 50.7%, 64.6% and 63.1% of that of control fibroblasts. These observations suggest that the defect in activation of the pyruvate dehydrogenase complex in these patients might be due to a reduction in pyruvate dehydrogenase phosphatase activity.